{"entity":{"id":"3ece6e4e-9b9c-5c13-b5dd-621c93071e15","name":"BEHRENS M KATHLEEN","type":"Person","kind":"person","jurisdiction":"US","identifier":"sec:0001211701","risk":"LOW","flags":[]},"identity":{"linked_records":[],"also_known_in":[]},"ownership":{"direct_owners":[],"holdings":[{"role":"director","share":null,"asset":{"id":"e5124c31-cdb6-50b8-9569-bb5ec4c8c48d","name":"Sarepta Therapeutics, Inc.","type":"Company","kind":"company"}},{"role":"director","share":null,"asset":{"id":"3608c469-3b96-5030-8ce2-c1e229f9225f","name":"IGM Biosciences, Inc.","type":"Company","kind":"company"}}],"ubo_chain":[]},"risk":{"level":"LOW","flags":[],"note":"Risk is a layer-1 signal (offshore-layering / connectivity heuristics) — an investigative lead, not a determination."},"sources":[{"registry":"sec_edgar","source_url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001211701"}],"source":"corpus"}